Fentanyl derivatives bearing aliphatic alkaneguanidinium moieties: a new series of hybrid molecules with significant binding affinity for mu-opioid receptors and I2-imidazoline binding sites.

[1]  M. Sastre,et al.  μ-Opioid receptor and α2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts , 1994, Psychopharmacology.

[2]  J. Pineda,et al.  Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2‐(2‐benzofuranyl)‐2‐imidazoline in rat locus coeruleus neurons , 2003, British journal of pharmacology.

[3]  S. Regunathan,et al.  Effect of chronic morphine treatment on the biosynthesis of agmatine in rat brain and other tissues. , 2002, Life sciences.

[4]  M. Carroll,et al.  Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats , 2002, Pharmacology Biochemistry and Behavior.

[5]  C. Dardonville,et al.  I(2)-imidazoline binding site affinity of a structurally different type of ligands. , 2002, Bioorganic & medicinal chemistry.

[6]  Ana Montero,et al.  Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening. , 2002, Bioorganic & medicinal chemistry.

[7]  G. Olmos,et al.  Activation of I2‐imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors , 2000, British journal of pharmacology.

[8]  D. Reis,et al.  Is agmatine a novel neurotransmitter in brain? , 2000, Trends in pharmacological sciences.

[9]  L. Stone,et al.  Moxonidine, a selective imidazoline/α 2 adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice , 2000, Pain.

[10]  G. Olmos,et al.  Attenuation of Tolerance to Opioid‐Induced Antinociception by Idazoxan and Other I2‐Ligands a , 1999, Annals of the New York Academy of Sciences.

[11]  G. Olmos,et al.  Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands , 1998, British journal of pharmacology.

[12]  A. Miralles,et al.  Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. , 1993, The Journal of pharmacology and experimental therapeutics.

[13]  James Lin,et al.  A mild and efficient method for the preparation of guanidines , 1992 .